These questions ask for details about the case including the location of all relevant documents, list of witnesses and the expected testimony of all experts
Long-term results and expectations beyond year one Research following semaglutide users beyond one year shows maintained weight loss in those who continue medication, with average losses stabilizing around 15 to 17 percent of starting weight
Other patients have been forced to ration or halt doses because the drugs are costly $1,000 to $1,300 per month and insurance coverage varies or because demand has far outstripped supply, Rothberg noted
Insurance companies typically dont cover the costs for drugs prescribed off-label, or they may require a prior authorization
Semaglutide (Ozempic and Wegovy) was found to be more effective than liraglutide (Saxenda and Victoza): overall, participants who took semaglutide lost 5.1 percent of their body weight, compared with just 2.2 percent among those taking liraglutide